COLLAGEN MEDICAL LLC
Doing business as COLLAGEN MEDICAL
- BOSTON, MA 02116-5755
- Partnership or Limited Liability Partnership
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 1
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
COLLAGEN MEDICAL LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About COLLAGEN MEDICAL LLC
- Headquarters
- BOSTON, MA 02116-5755
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIGJLBDQT8K757
- CAGE6A2D0
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $0
- Awards on record
- 1
- Top funding agencies
- n/a
Awards
HHSN268201400044C
Completed: Period of performance ended Aug 7, 2018IGF::OT::IGF SBIR TOPIC 85 TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING…
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.6M
- Period of performance
- Sep 8, 2014 – Aug 7, 2018
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
HHSN268201400044C IGF::OT::IGF SBIR TOPIC 85 TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING… | Department of Health and Human Services · National Institutes of Health | 541712 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.6M | Sep 8, 2014 – Aug 7, 2018 | Completed: Period of performance ended Aug 7, 2018 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 20 awards
- Total awarded
- $15,782,674
- By phase
- SBIR Phase I: 12
- SBIR Phase II: 8
- By agency
- Department of Health and Human Services: 20
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 1
- 2023: 1
- 2022: 1
- 2021: 3
- 2020: 1
- 2019: 1
- 2018: 1
- 2016: 1
- 2015: 5
- 2014: 1
- 2013: 3
- 2012: 1
Awards (most recent first)
Theranostic for gastric cancer
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,950,623
Sep 1, 2024 – Aug 31, 2026
Solicitation PA22-176 (2022) · Topic 102
Theranostic for gastric cancer
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $395,933
Sep 11, 2023 – Aug 31, 2024
Solicitation PA22-176 (2022) · Topic 102
PET imaging of radiation induced lung injury
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $1,996,724
Jun 1, 2022 – May 31, 2024
Solicitation PA19-273 (2019) · Topic 102
New class of collagen-targeted contrast agents for Magnetic Resonance Imaging
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $287,065
Sep 1, 2021 – May 31, 2022
Solicitation PA20-260 (2020) · Topic NIBIB
Targeted Imaging of Fibrosis in the Left Atrium
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,491,517
May 1, 2021 – Apr 30, 2023
Solicitation PA17-302 (2017) · Topic NIA
Molecular Imaging Agent to Detect Thrombus
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $496,849
Mar 1, 2021 – Feb 28, 2022
Solicitation PAR19-335 (2019) · Topic NHLBI
PET imaging of radiation induced lung injury
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $399,990
May 4, 2020 – Apr 30, 2021
Solicitation PA19-273 (2019) · Topic 102
Magnetic Particle Detection Test for Vulnerable Carotid Plaque
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $299,849
Sep 16, 2019 – Sep 15, 2020
Solicitation PA18-574 (2018) · Topic NIBIB
Targeted Imaging of Fibrosis in the Left Atrium
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $295,301
Aug 15, 2018 – Jul 31, 2019
Solicitation PA17-302 (2017) · Topic NIA
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $2,209,715
Sep 9, 2016 – Aug 31, 2019
Solicitation PA14-071 (2014) · Topic 102
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $280,588
Sep 24, 2015 – Aug 31, 2016
Solicitation PA14-071 (2015) · Topic 102
Fibrin Targeted Cancer Therapy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $242,178
May 18, 2015 – Apr 17, 2017
Solicitation PA14-071 (2015) · Topic 102
CM-65, a Targeted Contrast Agent for Cardiac Magnetic Resonance Perfusion Imaging
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $857,523
May 15, 2015 – Apr 30, 2018
Solicitation PA12-088 (2012) · Topic NHLBI
IGF OT IGF MR CONTRAST AGENT TO QUANTIFY MYOCARDIAL FIBROSIS SBIR TOPIC PHASE II
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $1,040,592
Solicitation year 2015 · Topic DHVD
IGF OT IGF SBIR TOPIC TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING MODALITIES TO DETECT HIGH RISK ATHEROSCLEROTIC PLAQUE
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $1,499,276
Solicitation year 2015 · Topic DBDR
IGF::OT::IGF SBIR Topic 85 To support the development of target specific molecular imaging agents in combination with existing imaging modalities to detect high risk atherosclerotic plaque.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $213,776
Solicitation year 2014 · Topic NHLBI · Research partner: Stub
CM-65, a Targeted Contrast Agent for Cardiac Magnetic Resonance Perfusion Imaging
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $207,280
Solicitation PA12-088 (2013) · Topic NHLBI · Research partner: Stub
Optimization of Efficacy and Safety Pharamacology of Fibrosis Imaging Agent CM-65
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $1,220,519
Solicitation PA11-096 (2013) · Topic NIDDK · Research partner: Stub
IGF::OT::IGF MR Contrast Agent to Quantify Myocardial Fibrosis - SBIR Topic 072 -
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $207,554
Solicitation year 2013 · Topic NHLBI · Research partner: Stub
Optimization of Efficacy and Safety Pharamacology of Fibrosis Imaging Agent CM-65
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $189,822
Solicitation PA11-096 (2012) · Topic NIDDK · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with COLLAGEN MEDICAL LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.